title: Partnership to decrease antipsychotic medication use in nursing homes: impact at the state level.
abstract: In 2012, the Centers for Medicare & Medicaid Services (CMS) established a partnership among stakeholders to decrease the percentage of residents in nursing homes receiving an antipsychotic agent by 15 percent. This goal emanated from concerns including the large percentage of residents taking antipsychotic agents, the questionable use of antipsychotics (e.g., off-label use), the high cost of inappropriate antipsychotic use, and toxicity in patients with dementia (e.g., black box warning regarding mortality). The successful achievement of this goal is evaluated via quality measures, which are greatly influenced by changes in exclusion of residents from the population examined. The partnership is focused on optimizing use of antipsychotic agents by training clinicians on nonpharmacologic approaches, educating on the dangers of antipsychotic medication use and sharing data on antipsychotic medications. In South Dakota, these efforts have yielded a 12 percent relative reduction (21.3 percent to 18.7 percent) in the percent of residents prescribed antipsychotic agents from the second quarter of 2012 to the second quarter of 2013. Future efforts in South Dakota include a Nursing Home Quality Care Collaborative that involves the majority of facilities across the state learning from peers and national experts. The South Dakota Dementia Coalition includes 17 stakeholders who guide education activities and communicate these opportunities to their constituents.
authors.forename: Jane R
authors.initials: JR
authors.lastname: Mort
authors.forename: Ryan
authors.initials: R
authors.lastname: Sailor
authors.forename: Lori
authors.initials: L
authors.lastname: Hintz
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D014487:Centers for Medicare and Medicaid Services, U.S.; D003704:Dementia / Q000517:prevention & control; D006801:Humans; D009735:Nursing Homes; D055818:Public-Private Sector Partnerships; D013023:South Dakota; D014481:United States
chemical_list: D014150:Antipsychotic Agents